Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
- Conditions
- Irritable Bowel SyndromeFunctional Bowel DisorderFunctional Abdominal Pain DisordersFunctional Abdominal Pain SyndromeFunctional Abdominal PainFunctional Gastrointestinal Disorders
- Interventions
- Other: Cognitive Behavioral TherapyOther: Low FODMAP Diet
- Registration Number
- NCT03823742
- Lead Sponsor
- Baylor College of Medicine
- Brief Summary
The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.
- Detailed Description
AIM 1: We will categorize children ages 7-12 yrs. of age with FGIDs (n=250) as to whether they have/do not have one or more of the following abnormal physiologic changes: a) Autonomic Nervous System imbalance as indicated by low heart rate variability; and/or (b) Abnormalities in gut physiology: Impaired gut barrier function (increased permeability); and/or increased abundance of species of Gammaproteobacteria and/or Clostridia; and/or Gut neuroimmune dysfunction (increased fecal chromogranin A and secretogranin 2 concentrations).
AIM 2: Children will be randomized to the two treatments most commonly used in clinical practice: CBT or a low FODMAP diet for a 3-week treatment period. We will compare the response to the treatments in those with/without abnormal physiologic biomarkers at 3 weeks, 3 months, and 6 months.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
- A child 7-12 years of age with a FGID will be recruited if the medical evaluation reveals no organic reason for the abdominal pain and the child has abdominal pain that meets the definition of a FGID (i.e., IBS, functional abdominal pain) according to the pediatric Rome III criteria (Rome IV will be substituted when validated). Parents and children must speak and understand English because of the psychological assessment and CBT requirements.
- Children who have: had past bowel surgery; documented GI disorders (e.g., Crohn's disease); a serious chronic medical condition (e.g., diabetes); weight and/or height < 2 SD for age; chronic conditions with GI symptoms (e.g., cystic fibrosis); autism spectrum disorder, significant developmental delay, psychosis, or a history of bipolar disorder; been treated with antibiotics/probiotics within 2 mo. (because of effects on gut microbiome analysis), and children who for some reason could not be randomized to the low FODMAP diet.Vegetarian; children who are currently on the FODMAP Diet or receiving CBT Children who speak only Spanish are not eligible because the Rome questionnaire and psychological testing are not available in Spanish. Despite this, a large proportion of the children enrolled will be Hispanic.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Cognitive Behavioral Therapy Cognitive Behavioral Therapy Cognitive Behavioral Therapy Low FODMAP diet Low FODMAP Diet Low FODMAP diet
- Primary Outcome Measures
Name Time Method Symptom Improvement 3 to 4 weeks Abdominal pain frequency or severity
- Secondary Outcome Measures
Name Time Method Improvement in quality of life 6 months PedsQL or Functional Disability
Symptom Improvement 6 months Abdominal pain frequency or severity
Trial Locations
- Locations (2)
Children's Nutrition Research Center
🇺🇸Houston, Texas, United States
Texas Children's Hospital
🇺🇸Houston, Texas, United States